Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation

• Үндсэн зохиолчид: Nurşah Eker (Зохиогч), Burcu Tufan Taş (Зохиогч), Ömer Doğru (Зохиогч), Emel Şenay (Зохиогч), Ayşe Gülnur Tokuç (Зохиогч), Ahmet Koç (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Galenos Yayinevi, 2022-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Autologous hematopoietic stem cell transplantation (AHSCT) is an increasingly used curative treatment for some solid tumors in children. Instead of allogeneic transplantation, the risk of developing graft-versus-host disease (GvHD) is much lower after AHSCT. Although the clinical findings of auto-GV...